Switzerland Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
October 22, 2014
102 Pages - SKU: BMI5361577
Countries covered: Switzerland

Switzerland Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The proportion of the pensionable population is high andgrowing, and this will translate into greater demand for drugs. Furthermore, the country's highly developedinfrastructure means that access to healthcare is easy, further supporting the consumption of medicines.

Headline Expenditure Projections

Pharmaceuticals: CHF7.06bn (USD7.68bn) in 2013 to CHF7.02bn (USD7.34bn) in 2014; -0.63% inlocal currency terms and -4.4% in US dollar terms.

Healthcare: CHF68.18bn (USD74.11bn) in 2013 to CHF69.45bn (USD72.61bn) in 2014; +1.9% growthin local currency terms and -2.0% in US dollar terms.



More Prescription Drugs reports by Business Monitor International

Sweden Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sweden Pharmaceuticals and Healthcare Report Q1 2015BMI View: Declining government reimbursement for prescription medicines does not bode well forinnovative drugmakers selling their products in Sweden, ...
Pakistan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Pakistan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Pakistan holds great potential for pharmaceutical and healthcare companies, with the world'ssixth largest population. However, poor medical ...
Nigeria Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Nigeria Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Nigerian government remains committed to improving healthcare quality andinfrastructure across the country. The formation of the ...
New Zealand Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
New Zealand Pharmaceuticals and Healthcare Report Q1 2015BMI View: With New Zealand's population ageing rapidly, underlying demand for health services andpharmaceuticals is high for the ...
See all reports like this >>

More Switzerland Prescription Drugs reports

The Pharmaceutical Market: Switzerland by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Switzerland (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Pharmaceuticals - Switzerland by Global Research & Data Services
This market analysis gives an overview of the actual situation, trends and future outlook of the pharmaceutical market in Switzerland. The market analysis provides essential ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!